Clinical Trial Update: A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion in Adult Subjects With Recurrent or Progressive Malignant Primary Brain Tumors（CROWN） [Phase 1]

View source ↗

Summary

Phase I, single-arm, open-label study to evaluate safety, pharmacokinetics, and preliminary efficacy of CHT101 cell infusion in adults with recurrent or progres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Drugs mentioned

• CHT101 cell infusion (CHT101)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Brain (Nervous System) Cancers | Phase 1 | Status: NOT_YET_RECRUITING